[{"NetIncomeLoss_2_Q2_USD":16180000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-1193000.0,"Depreciation_2_Q2_USD":1169000.0,"Depreciation_1_Q2_USD":607000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q2_USD":28700000.0,"IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories_2_Q2_USD":3567000.0,"AssetsCurrent_0_Q2_USD":132620000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":64000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":81000.0,"EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_1_Q2_USD":106000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":121837000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":52418000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":25136.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":25136.0,"PreferredStockLiquidationPreference_0_Q2_USD":4.0,"CommonStockSharesIssued_0_Q2_shares":20272000.0,"Assets_0_Q2_USD":158949000.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_Q2_shares":10000.0,"IncrementalCommonSharesAttributableToConversionOfPreferredStock_1_Q2_shares":10000.0,"ShareBasedCompensation_2_Q2_USD":1513000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"IncomeTaxesPaid_2_Q2_USD":4206000.0,"InventoryFinishedGoods_0_Q2_USD":21451000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"GeneralAndAdministrativeExpense_1_Q2_USD":6809000.0,"EarningsPerShareBasic_2_Q2_USD":0.81,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":20098000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":20154000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":593000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":338000.0,"AccountsReceivableNetCurrent_0_Q2_USD":2212000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":4476000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":2463000.0,"CommonStockValue_0_Q2_USD":20000.0,"ProceedsFromIncomeTaxRefunds_2_Q2_USD":285000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-916000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.217,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-11413000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-3600000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":106344000.0,"Liabilities_0_Q2_USD":22540000.0,"StockRepurchasedAndRetiredDuringPeriodShares_2_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":3000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":61000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.56,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.28,"GeneralAndAdministrativeExpense_2_Q2_USD":14563000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.226,"EarningsPerShareBasic_1_Q2_USD":0.42,"CommonStockSharesAuthorized_0_Q2_shares":40000000.0,"OperatingIncomeLoss_1_Q2_USD":10471000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":15188000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":20024000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":20063000.0,"LiabilitiesCurrent_0_Q2_USD":21162000.0,"AccountsPayableCurrent_0_Q2_USD":16058000.0,"NonoperatingIncomeExpense_2_Q2_USD":749000.0,"NonoperatingIncomeExpense_1_Q2_USD":404000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2613000.0,"AccruedIncomeTaxesCurrent_0_Q2_USD":618000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":860000.0,"GrossProfit_2_Q2_USD":49803000.0,"GrossProfit_1_Q2_USD":23018000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":11413000.0,"AdditionalPaidInCapital_0_Q2_USD":5317000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":106344000.0,"AdvertisingExpense_2_Q2_USD":14164000.0,"AdvertisingExpense_1_Q2_USD":5131000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":1378000.0,"PreferredStockSharesIssued_0_Q2_shares":3000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":25469000.0,"NetIncomeLoss_1_Q2_USD":8412000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":10875000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":20656000.0,"IncreaseDecreaseInPrepaidTaxes_2_Q2_USD":0.0,"EarningsPerShareDiluted_1_Q2_USD":0.42,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":0.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":147000.0,"InvestmentIncomeInterest_2_Q2_USD":156000.0,"InvestmentIncomeInterest_1_Q2_USD":66000.0,"PreferredStockValue_0_Q2_USD":9000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":408000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":158949000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"OperatingExpenses_2_Q2_USD":29896000.0,"OperatingExpenses_1_Q2_USD":12547000.0,"OperatingIncomeLoss_2_Q2_USD":19907000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":391000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1193000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":34000.0,"AssetsNoncurrent_0_Q2_USD":26329000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":171640000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":75436000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":131063000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":2582000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-1570000.0,"CommonStockSharesOutstanding_0_Q2_shares":20272000.0,"EarningsPerShareDiluted_2_Q2_USD":0.81,"StockholdersEquity_0_Q2_USD":136409000.0,"LiabilitiesAssumed1_2_Q2_USD":126000.0,"Ticker":"PETS","CIK":"1040130","name":"PETMED EXPRESS INC","OfficialName":"PetMed Express Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"531176354.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Nursing Services","Market":"NASDAQ","SP500":"nan","filed":"20201103"}]